In today's update the Company announces a series of moves now underway as a basis for emphasized priorities on transparency, full and accurate public reporting plus operational readiness to meet the accelerating, pandemic-drive demand for its clinical services.
In this light, the Company reminds investors it is now led by a new Board Chair and CEO and new Vice-Chair, both announced previously (see news release dated
- The Company is now actively recruiting a new Chief Financial Officer, Chief General Counsel, and Senior Vice President –
Investor and Public Communications .
- The Company intends to expand its board with additional outside directors to be drawn from business and science.
- The Company has accepted the resignation of
Gareth Birdsall , director, effectiveNovember 23, 2020 .
- The Company has re-designed its website to facilitate proper access to current information by investors and the wider public.
The current Board of Directors consists of Dr.
SOURCE
© Canada Newswire, source